1. Home
  2. RCKT vs CYRX Comparison

RCKT vs CYRX Comparison

Compare RCKT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.86

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

CYRX

CryoPort Inc.

HOLD

Current Price

$10.05

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKT
CYRX
Founded
1999
1999
Country
United States
United States
Employees
202
1100
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
534.2M
419.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
RCKT
CYRX
Price
$3.86
$10.05
Analyst Decision
Buy
Strong Buy
Analyst Count
14
9
Target Price
$29.73
$12.94
AVG Volume (30 Days)
4.2M
404.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.22
EPS
N/A
1.40
Revenue
N/A
$176,177,000.00
Revenue This Year
N/A
$11.06
Revenue Next Year
$69.83
$8.45
P/E Ratio
N/A
$7.11
Revenue Growth
N/A
N/A
52 Week Low
$2.19
$5.21
52 Week High
$8.26
$11.45

Technical Indicators

Market Signals
Indicator
RCKT
CYRX
Relative Strength Index (RSI) 48.29 71.38
Support Level $2.99 $9.18
Resistance Level $4.08 $10.23
Average True Range (ATR) 0.31 0.42
MACD -0.01 0.18
Stochastic Oscillator 27.86 90.10

Price Performance

Historical Comparison
RCKT
CYRX

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: